Wolf Myles has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 35700 shares of Akebia Therapeutics, Inc. ($AKBA) on June 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Common Stock | 35700 | $0.00 | 133,381.0000 | 210,946,658 | 36.55% | 0.02% |
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Stock Option (Right to buy) | 53600 | $0.00 | 53,600.0000 | 210,946,658 | 9999.99% | 0.03% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Common Stock | 30000 | $0.00 | 97,681.0000 | 187,465,448 | 44.33% | 0.02% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 187,465,448 | 9999.99% | 0.02% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Common Stock | 30000 | $0.00 | 67,681.0000 | 0 | 79.62% | 0.00% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | Wolf Myles | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |